Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunovant, Inc. | 242,107 | reported | 20 May 2026 | tx 12+430,880−18,979 |
| ACELYRIN, Inc. | 184,042 | reported | 23 May 2024 | tx 11+1,801,964−760,903 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | SALE | Immunovant, Inc. | 249 | 30.41 USD | |
| 20 May 2026 | SALE | Immunovant, Inc. | 1,168 | 32.15 USD | |
| 20 May 2026 | SALE | Immunovant, Inc. | 1,698 | 32.95 USD | |
| 25 Feb 2026 | SALE | Immunovant, Inc. | 942 | 28.90 USD | |
| 25 Feb 2026 | SALE | Immunovant, Inc. | 859 | 28.16 USD | |
| 25 Feb 2026 | SALE | Immunovant, Inc. | 1,437 | 26.98 USD | |
| 20 Nov 2025 | SALE | Immunovant, Inc. | 10,251 | 23.54 USD | |
| 20 Nov 2025 | SALE | Immunovant, Inc. | 2,375 | 23.97 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 76,181 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 107,297 | 0.00 USD | deriv |
| 18 Nov 2024 | GRANT_AWARD | Immunovant, Inc. | 109,956 | 0.00 USD | |
| 18 Nov 2024 | GRANT_AWARD | Immunovant, Inc. | 137,446 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | ACELYRIN, Inc. | 184,042 | 0.00 USD | deriv |
| 15 May 2024 | TAX_WITHHOLDING | ACELYRIN, Inc. | 10,298 | 4.47 USD | |
| 09 Jan 2024 | GRANT_AWARD | ACELYRIN, Inc. | 494,297 | 0.00 USD | deriv |
| 16 Aug 2023 | GRANT_AWARD | ACELYRIN, Inc. | 140,584 | 0.00 USD | |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 232,436 | 0.00 USD | deriv |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 330,181 | 0.00 USD | deriv |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 232,436 | 0.00 USD | deriv |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 187,988 | 0.00 USD | deriv |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 187,988 | 0.00 USD | deriv |
| 09 May 2023 | OTHER | ACELYRIN, Inc. | 330,181 | 0.00 USD | deriv |
| 04 May 2023 | GRANT_AWARD | ACELYRIN, Inc. | 232,436 | 0.00 USD | deriv |